The Regeneron antibody drug cocktail – casirivimab and imdevimab – has been added to the World Health Organization’s (WHO) list of treatments for COVID-19 patients, the UN agency said on Friday, before underscoring the need for lower prices and equitable distribution.
Hiroshima fosters hope, 81 years on from nuclear catastrophe 
The Year of Pastoralists Must Be More Than Symbolic 
Rohingya Refugees Seeking Safe Haven in Bangladesh Hit by Fresh Disasters